Clinical trial
Bicalutamide in Treating Patients With Metastatic Breast Cancer
NCT00468715
Study timeline
Study start (actual)2007-03-23Date precision: day
Registry last updated2022-08-03
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Breast Cancerunresolved
Interventions
bicalutamideDRUG · verified · RxNorm: bicalutamide
Sponsors & collaborators
Memorial Sloan Kettering Cancer Centerlead sponsor
National Cancer Institute (NCI)collaborator
AstraZenecacollaborator
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT00468715 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.